Back to
Rafferty Asset Management, LLC
BBIO27 quarters
Position history for
Rafferty Asset Management, LLC's holdings in BRIDGEBIO PHARMA INC
Rafferty Asset Management, LLC holds 40,953 shares of BBIO (BRIDGEBIO PHARMA INC), worth $3.1M as of 2026-Q2. The position was decreased (-35.2% shares). BBIO represents 0.0% of Rafferty Asset Management, LLC's portfolio.
Current Value
$3.1M
Current Shares
40,953
Total Value Change
+$2.4M
Total Shares Change
+21,705
Quarter-by-Quarter History
Other major holders of BBIO: VIKING GLOBAL INVESTORS LP, VANGUARD GROUP INC